Cite
Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis.
MLA
Naito, Yoshiki, et al. “Significance of Neoadjuvant Chemoradiotherapy for Borderline Resectable Pancreatic Head Cancer: Pathological Local Invasion and Microvessel Invasion Analysis.” Molecular & Clinical Oncology, vol. 11, no. 3, Sept. 2019, pp. 225–33. EBSCOhost, https://doi.org/10.3892/mco.2019.1885.
APA
Naito, Y., Ishikawa, H., Sadashima, E., Okabe, Y., Takahashi, K., Kawahara, R., Hisaka, T., Fukahori, M., Ushijima, T., Ishida, Y., Tanigawa, M., Mihara, Y., Nakayama, M., Kondo, R., Kusano, H., Takase, Y., Abe, H., Ogo, E., Okuda, K., & Shimamatsu, K. (2019). Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis. Molecular & Clinical Oncology, 11(3), 225–233. https://doi.org/10.3892/mco.2019.1885
Chicago
Naito, Yoshiki, Hiroto Ishikawa, Eiji Sadashima, Yoshinobu Okabe, Kenjiro Takahashi, Ryuichi Kawahara, Toru Hisaka, et al. 2019. “Significance of Neoadjuvant Chemoradiotherapy for Borderline Resectable Pancreatic Head Cancer: Pathological Local Invasion and Microvessel Invasion Analysis.” Molecular & Clinical Oncology 11 (3): 225–33. doi:10.3892/mco.2019.1885.